Sunday, April 12, 2026
wellness India Expo

Editor’s Zone

This space is for the Editor’s critical take on the various issues of importance that have happened during the week. The inside review of various initiatives, developments and the news that mattered most. Few a times, its a bitter pill yet next time a sweet candy, the ‘Editor’s Zone’ acts as an applauder, neutral observer and critic depending on the objectivity.

Feel free to connect with the Editor at rk@biovoicenews.com

Face to Face

“Research must be designed for translation, not just for publications”: Dr...

303
Dr Sagar Sengupta, Director, National Institute of Biomedical Genomics (NIBMG) and Director (Additional Charge), National Brain Research Centre (NBRC) shared his insights on the latest initiatives, importance of industry-academia collaboration, increased government funding, and evolution of research ecosystem

Chat with BioVoice

“Biologics and biosimilars represent Veeda’s second-highest strategic priority after clinical trials”

143
Binoy Gardi, Managing Director and Group CEO, Veeda Lifesciences shared insights on his latest role and top priorities; the company's latest initiatives, outcomes of key acquisitions and future plans

R&D

Events